What Is CBG Certification?

What Clinical Biochemical Genetics Certification Actually Is

Clinical Biochemical Genetics, abbreviated CBG throughout this site, is a board certification for professionals who diagnose and interpret inherited metabolic disease. The credential sits at the intersection of laboratory science and clinical medicine. A certified specialist reads a plasma amino acid profile, an acylcarnitine panel, or a urine organic acid chromatogram and translates it into a diagnosis, a treatment recommendation, and a family counseling message.

The acronym is shared with unrelated credentials in other fields, so it helps to be precise. When we say CBG, we mean the biochemical genetics specialty certified through the American Board of Medical Genetics and Genomics. If you are searching for a different certification that happens to use the same three letters, the content below will not apply. For a broader discussion of the abbreviation itself, see our explainers on what CBG is and what CBG stands for.

The credential matters because inborn errors of metabolism are individually rare but collectively common. Newborn screening programs flag thousands of abnormal results every year, and each flagged result needs someone who can distinguish a true positive from an artifact, a carrier from an affected infant, and a treatable emergency from a benign variant. That interpretive skill is precisely what the certification is designed to verify.

Who Issues It and What the Blueprint Says

The certifying body is the American Board of Medical Genetics and Genomics. ABMGG publishes content outlines and blueprints for each of its specialties, and the Biochemical Genetics blueprint is the single most useful document a candidate can download. The version this article draws on is the ABMGG Biochemical Genetics Blueprint and Content Codes effective August 2025. You can find the official materials on the ABMGG content outlines and blueprints page.

One practical wrinkle: the ABMGG index page references 2026 outlines, while the supplied blueprint carries an August 2025 effective date. Candidates should confirm on the ABMGG site which document governs their exam cycle before building a study plan around any single percentage figure.

The Fifteen Content Categories at a Glance

The blueprint organizes the exam into fifteen categories. The approximate weights below are preserved exactly as published. They total 102% because of a discrepancy in the source total, and they are deliberately not normalized here. Use them as directional guidance, not as precise question counts.

For a category-by-category walkthrough, our complete guide to all 15 content areas goes deeper than we can here.

Where the Weight Sits: Amino Acids, Lipids, Organic Acids, and Lysosomes

Four categories together account for roughly half of the blueprint: Amino acids (15%), Lipids (13%), Organic acids (12%), and Lysosomes (12%). A candidate who is fluent in these four has a strong foundation before touching anything else.

The Smaller Categories You Cannot Ignore

It is tempting to skip a 1% or 3% category. That is a mistake for two reasons. First, the weights are approximate, so a small category may contribute more items than its percentage suggests. Second, the small categories are often where candidates lose points they could easily have earned, because fewer people review them thoroughly.

Cofactors, Carbohydrates, and Mitochondria

Cofactors (about 7%) spans cobalamin, biotin, molybdenum, folate, pyridoxine, biopterin, and others including riboflavin, niacin, and thiamine. This category rewards understanding of why a vitamin-responsive condition responds, which ties directly back to the amino acid and organic acid categories. Carbohydrates (about 10%) covers glycogenoses (excluding GSD II, which is handled with the lysosomal disorders), glycolysis and gluconeogenesis defects, galactose and fructose disorders, congenital disorders of glycosylation, and pentose phosphate pathway conditions. Mitochondria (about 7%) includes Leigh syndrome, electron transport chain function and assembly, mtDNA mutation and maintenance disorders, depletion syndromes, and MELAS.

Low-Weight Categories

• Peroxisomes (about 3%): biogenesis disorders such as Zellweger syndrome, single-enzyme disorders such as X-linked adrenoleukodystrophy, and conditions like infantile Refsum disease.
• Purines and pyrimidines (about 3%): Lesch-Nyhan disease, adenosine deaminase deficiency, and UMP synthase deficiency.
• Transport (about 3%): dibasic aminoaciduria including cystinuria and lysinuric protein intolerance, other amino acid transport disorders, glucose, and carnitine.
• Creatine (about 1%): the smallest category on the blueprint.
• Neurotransmitters (about 2%): SSADH deficiency, dopamine synthesis disorders, and GABA metabolism.
• Metals (about 3%): copper (Wilson and Menkes diseases), iron, zinc, and others.
• Other disease category (about 3%): a catch-all for conditions outside the named groupings.

The Laboratory Category: A Different Kind of Question

The Laboratory category carries about 8% of the blueprint, and it behaves differently from the disease-focused categories. It covers QA/QC, artifact, techniques, and regulations. Instead of asking you to name an enzyme defect, these items test whether you can run, validate, and troubleshoot the assays that produce the diagnosis.

Practically, that means you should be comfortable with how a mass spectrometry or chromatography result can be distorted by medication, diet, sample handling, or contamination. Artifact recognition is a recurring theme: a spurious peak or an unexpectedly elevated analyte may reflect something other than disease. You should also understand quality control principles and the regulatory framework governing clinical laboratories. This is the category where hands-on bench experience pays off most visibly, and where candidates who trained only on clinical cases may feel less prepared.

Exam Schedule and What Is Not Published

ABMGG has approved a transition to an annual certifying examination schedule, described on its news page. Within that schedule, biochemical specialties are offered in odd years. The next CBG exam is identified as August 2027, and ABMGG has announced that the 2027 certification exams will take place August 11 to 14, 2027, per its 2027 exam announcement.

That odd-year pattern has a real planning consequence. Missing one cycle can mean a long wait, so build your timeline backward from the exam window rather than forward from whenever you feel ready. Our CBG exam dates guide covers scheduling and deadlines in more detail.

Equally important is what this article does not claim. The question count, exam timer, fee schedule, and passing score were not established from the supplied official source content, so we have deliberately left them out rather than guess. Confirm each of these directly with ABMGG before you budget or plan. For cost and scoring background as it becomes verifiable, see our pricing breakdown and the passing score guide, and check eligibility on the requirements page.

Who Uses This Credential

The certification serves people whose daily work involves interpreting biochemical results in a genetic context. In practice that includes laboratory directors and clinical laboratory geneticists in hospital and reference laboratories, biochemical genetics laboratory staff involved in newborn screening follow-up and diagnostic testing, and physicians in medical genetics programs who manage patients with metabolic disease. Academic medical centers with metabolic clinics, public health newborn screening programs, and commercial reference laboratories are the typical environments.

We are not going to quote salary figures here because we do not have verified numbers for this specific credential. If compensation and return on investment drive your decision, our analyses of earnings and whether the certification is worth it frame the question qualitatively, and our overview of CBG jobs describes the roles where the credential is most relevant.

Sequencing Your Preparation Around the Blueprint

You do not need a generic study system; you need a sequence that respects how these categories depend on each other. The ordering below is one reasonable approach, built around the blueprint rather than around a calendar fad. Adjust the pacing to your own timeline and background.

For a fuller plan, see our CBG study guide, and keep the one-page cheat sheet handy for last-week review. If you want to gauge how demanding the material is before committing, read our difficulty guide and the discussion of the pass rate.

Where to Go Next

This page is the overview. Depending on your question, these are the natural next steps:

• Confirming you qualify: CBG requirements.
• Planning your timeline: CBG exam dates.
• Understanding the content: all 15 content areas.
• Building a plan: the study guide.
• Testing yourself: the full practice test library.

Whichever route you take, anchor your preparation to the official ABMGG blueprint and re-check it for updates, since the credential's published materials can change between cycles. You can also review the official Biochemical Genetics blueprint PDF directly.

Frequently Asked Questions

Clinical Biochemical Genetics certification rewards candidates who can move fluidly between laboratory data and clinical reasoning. Start from the blueprint, weight your effort toward the largest categories without neglecting the small ones, and verify every administrative detail with ABMGG.